Counterfactuals of Effects of Vaccination and Public Health Measures on COVID-19 Cases in Canada: What Could Have Happened?

Overview

Journal Front Public Health

Specialty Public Health

Date 2023 May 25

PMID 37228725

Authors

David M Vickers

John Hardie

Stefan Eberspaecher

Claudia Chaufan

Steven Pelech

Affiliations

Soon will be listed here.

References

Berry C, Fowler A, Glazer T, Handel-Meyer S, MacMillen A . Evaluating the effects of shelter-in-place policies during the COVID-19 pandemic. Proc Natl Acad Sci U S A. 2021; 118(15). PMC: 8053946. DOI: 10.1073/pnas.2019706118. View

Ng K, Faulkner N, Cornish G, Rosa A, Harvey R, Hussain S . Preexisting and de novo humoral immunity to SARS-CoV-2 in humans. Science. 2020; 370(6522):1339-1343. PMC: 7857411. DOI: 10.1126/science.abe1107. View

Smith S, Sonego S, Wallen G, Waterer G, Cheng A, Thompson P . Use of non-pharmaceutical interventions to reduce the transmission of influenza in adults: A systematic review. Respirology. 2015; 20(6):896-903. PMC: 4699551. DOI: 10.1111/resp.12541. View

Guthmiller J, Wilson P . Remembering seasonal coronaviruses. Science. 2020; 370(6522):1272-1273. DOI: 10.1126/science.abf4860. View

Alexander P, Armstrong R, Fareed G, Lotus J, Oskoui R, Prodromos C . Early multidrug treatment of SARS-CoV-2 infection (COVID-19) and reduced mortality among nursing home (or outpatient/ambulatory) residents. Med Hypotheses. 2021; 153:110622. PMC: 8178530. DOI: 10.1016/j.mehy.2021.110622. View

Kundu R, Narean J, Wang L, Fenn J, Pillay T, Fernandez N . Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts. Nat Commun. 2022; 13(1):80. PMC: 8748880. DOI: 10.1038/s41467-021-27674-x. View

Jefferson T, Del Mar C, Dooley L, Ferroni E, Al-Ansary L, Bawazeer G . Physical interventions to interrupt or reduce the spread of respiratory viruses. Cochrane Database Syst Rev. 2020; 11:CD006207. PMC: 8094623. DOI: 10.1002/14651858.CD006207.pub5. View

DeMartino G . The specter of irreparable ignorance: counterfactuals and causality in economics. Rev Evol Polit Econ. 2024; 2(2):253-276. PMC: 7792558. DOI: 10.1007/s43253-020-00029-w. View

Yu X, Tsibane T, McGraw P, House F, Keefer C, Hicar M . Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature. 2008; 455(7212):532-6. PMC: 2848880. DOI: 10.1038/nature07231. View

10.

Kory P, Meduri G, Varon J, Iglesias J, Marik P . Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19. Am J Ther. 2021; 28(3):e299-e318. PMC: 8088823. DOI: 10.1097/MJT.0000000000001377. View

11.

Ogden N, Fazil A, Arino J, Berthiaume P, Fisman D, Greer A . Modelling scenarios of the epidemic of COVID-19 in Canada. Can Commun Dis Rep. 2020; 46(8):198-204. PMC: 7343050. DOI: 10.14745/ccdr.v46i06a08. View

12.

Petrocelli J . Pitfalls of counterfactual thinking in medical practice: preventing errors by using more functional reference points. J Public Health Res. 2014; 2(3):e24. PMC: 4147742. DOI: 10.4081/jphr.2013.e24. View

13.

Vickers D, Baral S, Mishra S, Kwong J, Sundaram M, Katz A . Stringency of containment and closures on the growth of SARS-CoV-2 in Canada prior to accelerated vaccine roll-out. Int J Infect Dis. 2022; 118:73-82. PMC: 8863413. DOI: 10.1016/j.ijid.2022.02.030. View

14.

Ogden N, Turgeon P, Fazil A, Clark J, Gabriele-Rivet V, Tam T . Counterfactuals of effects of vaccination and public health measures on COVID-19 cases in Canada: What could have happened?. Can Commun Dis Rep. 2023; 48(7-8):292-302. PMC: 10275398. DOI: 10.14745/ccdr.v48i78a01. View

15.

McCullough P, Kelly R, Ruocco G, Lerma E, Tumlin J, Wheelan K . Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection. Am J Med. 2020; 134(1):16-22. PMC: 7410805. DOI: 10.1016/j.amjmed.2020.07.003. View

16.

Ioannidis J . Infection fatality rate of COVID-19 inferred from seroprevalence data. Bull World Health Organ. 2021; 99(1):19-33F. PMC: 7947934. DOI: 10.2471/BLT.20.265892. View

17.

Mateus J, Grifoni A, Tarke A, Sidney J, Ramirez S, Dan J . Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans. Science. 2020; 370(6512):89-94. PMC: 7574914. DOI: 10.1126/science.abd3871. View

18.

Risch H . Early Outpatient Treatment of Symptomatic, High-Risk COVID-19 Patients That Should Be Ramped Up Immediately as Key to the Pandemic Crisis. Am J Epidemiol. 2020; 189(11):1218-1226. PMC: 7546206. DOI: 10.1093/aje/kwaa093. View

19.

Goolsbee A, Syverson C . Fear, lockdown, and diversion: Comparing drivers of pandemic economic decline 2020. J Public Econ. 2020; 193:104311. PMC: 7687454. DOI: 10.1016/j.jpubeco.2020.104311. View

20.

. Variation in the COVID-19 infection-fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis. Lancet. 2022; 399(10334):1469-1488. PMC: 8871594. DOI: 10.1016/S0140-6736(21)02867-1. View